Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The pharmacological treatment of mood disorders remains focused around the use of monoamine potentiating agents for the management of depression. There are, however, a growing number of agents available for management of bipolar disorder, with both anticonvulsants and atypical antipsychotic drugs showing promise in the management of bipolar depression. © 2006 Elsevier Ltd. All rights reserved.

Original publication

DOI

10.1383/psyt.2006.5.5.162

Type

Journal article

Journal

Psychiatry

Publication Date

01/05/2006

Volume

5

Pages

162 - 166